πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,152 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7749967

Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jul 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7749984

Computer-based model for identification and characterization of non-competitive inhibitors

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jul 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7749719

Melanoma antigens and their use in diagnostic and therapeutic methods

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jul 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7745144

Peptides and their utility in modulation of behavior of cells expressing Ξ±3Ξ²1 integrins

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7745212

Melanoma antigens and their use in diagnostic and therapeutic methods

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7744902

Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7741437

P. ariasi polypeptides, p. perniciosus polypeptides and methods of use

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 22 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7740889

Bacteriocins and novel bacterial strains

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jun 22 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7741063

Toxoplasma gondii oocyst protein

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jun 22 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7731939

Vaccine compositions and adjuvant

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7731953

Methods for use of TSLP and agonists and antagonists thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7723096

Agonist peptides of carcinoembryonic antigen (CEA) and nucleic acid sequences encoding the

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7723500

Immunostimulatory nucleic acid molecules

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7723111

Activated dual specificity lymphocytes and their methods of use

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7723022

Immunostimulatory nucleic acid molecules

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7718196

Rapamycin-resistant T cells and therapeutic uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7718424

AAV4 vector and uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7713529

Methods for treating and preventing infectious disease

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7709007

Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide seque

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7709252

Antibodies, including FV molecules, and immunoconjugates having high binding affinity for

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7709002

Mutated ras peptides for generation of CD8+Cytotoxic T lymphocytes

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7704491

Recombinant human metapneumovirus and its use

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7700273

Peptidomimetics that mimic a conformational-dependent neutralizing epitope of the human im

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7696338

Immunotoxin fusion proteins and means for expression thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted